|
Volumn 39, Issue 5, 2001, Pages 185-191
|
Drug treatment in pregnancy
a a |
Author keywords
Drug treatment; Pharmacoepidemiology; Pregnancy
|
Indexed keywords
AMPICILLIN;
ANALGESIC AGENT;
ANDROGEN;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIDIABETIC AGENT;
ANTIEMETIC AGENT;
ANTIHISTAMINIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIMETABOLITE;
CARBAMAZEPINE;
COUMARIN;
DIETHYLSTILBESTROL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG METABOLITE;
ERGOT ALKALOID;
ISOTRETINOIN;
LITHIUM;
METHYLPREDNISOLONE;
PHENYTOIN;
PSYCHOTROPIC AGENT;
RETINOID;
SUMATRIPTAN;
THALIDOMIDE;
TIRILAZAD;
UNINDEXED DRUG;
VALPROIC ACID;
XENOBIOTIC AGENT;
ABORTION;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AREA UNDER THE CURVE;
CHILD;
CONTROLLED STUDY;
COUNSELING;
DEVELOPMENT;
DIABETES MELLITUS;
DIAGNOSIS;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG THERAPY;
EMBRYO;
EMBRYOPATHY;
EPIDEMIOLOGY;
EPILEPSY;
ETHICS;
FEASIBILITY STUDY;
FEMALE;
FETUS;
GROWTH RETARDATION;
HUMAN;
INFORMATION;
MONITORING;
MOTHER;
PHYSIOLOGY;
POPULATION;
PREGNANCY;
REVIEW;
RISK;
TERATOGENICITY;
|
EID: 0035043075
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP39185 Document Type: Review |
Times cited : (13)
|
References (44)
|